EMILY ANDREWS: Open Payments
NPI 1558746081 · CROOKSTON, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 23 payments from 13 companies in 2025. Trend: 2023 $1,078 · 2024 $1,282 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $89 |
| Novo Nordisk Inc | 4 | $71 |
| Abbott Laboratories | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| ABBVIE INC. | 2 | $38 |
| Lilly USA, LLC | 2 | $31 |
| Seqirus USA Inc | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Ascensia Diabetes Care Us Inc. | 1 | $19 |
Products named: Veozah, FREESTYLE LIBRE 3, SPRAVATO, Wegovy, MOUNJARO, Fluad, QULIPTA, TRINTELLIX.
Industry payments across MN — which companies pay providers there.
